Frank Rimerman Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Sell |
4,656
-269
| -5% | -$109K | 0.13% | 125 |
|
|
2025
Q1 | $2.45M | Buy |
4,925
+104
| +2% | +$51.8K | 0.19% | 88 |
|
|
2024
Q4 | $2.51M | Buy |
4,821
+140
| +3% | +$72.8K | 0.18% | 85 |
|
|
2024
Q3 | $2.9M | Buy |
4,681
+83
| +2% | +$51.3K | 0.21% | 80 |
|
|
2024
Q2 | $2.54M | Buy |
4,598
+4,574
| +19,058% | +$2.53M | 0.18% | 92 |
|
|
2024
Q1 | $13.9K | Hold |
24
| – | – | ﹤0.01% | 164 |
|
|
2023
Q4 | $12.7K | Buy |
+24
| New | +$12.7K | ﹤0.01% | 162 |
|
|
2022
Q2 | – | Sell |
-1,845
| Closed | -$1.09M | – | 125 |
|
|
2022
Q1 | $1.09M | Hold |
1,845
| – | – | 0.35% | 38 |
|
|
2021
Q4 | $1.23M | Buy |
1,845
+247
| +15% | +$165K | 0.41% | 36 |
|
|
2021
Q3 | $913K | Buy |
+1,598
| New | +$913K | 0.35% | 39 |
|